National Centre for Parasitology, Entomology and Malaria Control, Cambodia Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Phnom Penh Cambodia (2004)

Organization Overview

First Clinical Trial
2005
NCT01594931
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Cambodian National Centre for Parasitology Entomology and Malaria Control | National Centre for Parasitology, Entomology and Malaria Control, Cambodia | National Centre for Parasitology,Entomology and Malaria Control, Phnom Penh,Cambodia

Active Ingredients

Drugs in Phase 4 Trials (6)

artesunate (3 trials)

atovaquone (mepron) (1 trial)

dihydroartemisinin (2 trials)

piperaquine (4 trials)

primaquine (5 trials)

proguanil (1 trial)

Drugs in Phase 3 Trials (3)

ivermectin (stromectol) (2 trials)

moxidectin (2 trials)

tafenoquine succinate (arakoda) (1 trial)

Drugs in Phase 2 Trials (1)

pyronaridine (1 trial)

Drugs in Other Trials (1)

artemisinin (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glucosephosphate Dehydrogenase Deficiency (Phase 4)

Malaria (Phase 4)

Malaria, Falciparum (Phase 4)

Malaria, Vivax (Phase 3)

Strongyloidiasis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 11